Pay in 4 interest-free payments of $5.22 Learn more
Ships within 48 hours · Estimated delivery Aug 18 - Aug 23
Unlike single-pathway incretin peptides, Retatrutide is researched for its interaction across GLP-1, GIP, and glucagon receptor systems
doi: 10.2337/dc25-S009
Until comprehensive Phase 3 safety data are available and reviewed by regulators such as the MHRA, the full safety profile of retatrutide in diverse patient populations remains incompletely characterised
The medication comes from licensed 503A compounding pharmacies and serves all 50 states
US$ 26.43
US$ 29.51
US$ 29.10
US$ 27.64
US$ 29.00
US$ 20.86
US$ 23.29
US$ 24.90
